MedPath

Effects of Lycopene on Oxidative Stress and Markers of Endothelial Function Healthy Men

Phase 3
Completed
Conditions
Healthy Men
Interventions
Dietary Supplement: lycopene
Registration Number
NCT01221558
Lead Sponsor
Yonsei University
Brief Summary

The hypothesis was that an increase in serum lycopene levels following supplementation with capsules containing natural lycopene rich tomato extract would reduce oxidative stress and improve endothelial function in healthy men with low intake of fruits and vegetables. A randomized double-blind, placebo-controlled study was designed to assess the changes in serum lycopene levels, oxidative stress and endothelial function in response to an 8-week treatment with lycopene supplementation.

Detailed Description

The healthy men aged 20-60 years, who frequently smoked cigarettes or consumed alcohol, were enrolled in this study. Subjects were excluded if they consumed more than 3 servings/day of vegetables and fruit, or more than one serving/week of lycopene-rich foods; took antioxidant, vitamin, or mineral supplements; had any history of chronic disease; or were taking lipid-lowering or antihypertensive medications.The subjects were randomly assigned to receive placebo, 6mg, or 15mg lycopene capsule per day for 8 weeks. Study substances were suspended in soybean oil and given in acid-soluble gelatin capsules. A placebo containing soybean oil (100%) was supplied in identical-looking capsules. All the subjects were instructed to consume one capsule per day right after any meal of their choice. All participants were encouraged to maintain their usual lifestyle and dietary habits.

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
126
Inclusion Criteria
  • healthy men who frequently smoked cigarettes or consumed alcohol
Exclusion Criteria
  • consumption of more than 3 servings/day of vegetables and fruit, or more than one serving/week of lycopene-rich foods
  • taking antioxidant, vitamin, or mineral supplements
  • any history of chronic disease (diabetes, heart disease, renal disease)
  • taking lipid-lowering or antihypertensive medications

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
6mg lycopenelycopene-
15mg lycopenelycopene-
placebolycopene-
Primary Outcome Measures
NameTimeMethod
lymphocyte DNA damage8 weeks
antioxidant enzymes : SOD, GSH-Px, Catalase8 weeks
lipid peroxidation marker : MDA, urinary 8 epi-PGF 2alpha8 weeks
oxidized LDL8 weeks
Secondary Outcome Measures
NameTimeMethod
Reactive hyperemia peripheral arterial tonometry (RH-PAT) index8 weeks
VCAM-1/ICAM-18 weeks
cytokines : IL-6, TNF-alpha, IL-1beta8 weeks
hs-CRP8 weeks

Trial Locations

Locations (1)

Laboratory of Clinical Nutrigenetics/Nutrigenomics, Yonsei University.

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath